The deal size was increased to $300M from $250M and priced at low end of $45.80-$47.80 range. Goldman Sachs is acting as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NTLA:
- Here’s Why Intellia (NASDAQ:NTLA) Stock Is Trending Lower
- Intellia Therapeutics to participate in a conference call with JPMorgan
- Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
- Intellia Therapeutics $250M Spot Secondary; price range $45.80-$47.80
- Intellia Therapeutics announces $250M common stock offering